增加PRIM2表达与胰腺管道腺癌患者的预后不佳有关
Jingyang Yin, Shixiang Guo1, Jiali Yang1
1Institute of Hepatopancreatobiliary Surgery, Chongqing General Hospital, Chongqing University, Chongqing, China.
Pancreas
|September 11, 2024
概括
在胰腺管腺癌 (PDAC) 中高PRIM2表达表明预后不佳. 这一发现表明PRIM2可以作为PDAC患者的独立风险指标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 手术病理学手术病理学
背景情况:
- 胰腺管腺癌 (PDAC) 仍然是瘤学的重大挑战.
- 确定可靠的预后生物标志物对于改善患者的治疗结果至关重要.
研究的目的:
- 调查PRIM2基因表达与被诊断患有PDAC的患者的预后之间的相关性.
- 确定PRIM2表达水平是否可以作为PDAC的独立预后因素.
主要方法:
- 组织微阵列 (TMA) 分析来自127名PDAC患者的样本.
- 免疫组织化学 (IHC) 用于量化PRIM2表达水平.
- 统计分析评估了与临床病理特征和生存相关的关联,并使用公共数据库数据进行验证.
主要成果:
- 发现PRIM2在PDAC组织中表达很高.
- 增加的PRIM2表达与较差的患者预后和更高的病理等级相关 (P = 0.050).
- 多变量分析确定高PRIM2表达是减少生存时间的独立风险因素 (HR,1.78;P = 0.031).
结论:
- 高PRIM2表达与胰腺管道腺癌的预后不佳显著相关.
- PRIM2显示出作为PDAC患者风险分层的有价值的独立生物标志物的潜力.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K